<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
43624-015-01
</NDCCode>
<PackageDescription>
168 VIAL, SINGLE-USE in 1 TRAY (43624-015-01) / .5 mL in 1 VIAL, SINGLE-USE
</PackageDescription>
<NDC11Code>
43624-0015-01
</NDC11Code>
<ProductNDC>
43624-015
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Tirzepatide
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20230801
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
BSP Pharmaceuticals SpA
</LabelerName>
<SubstanceName>
TIRZEPATIDE
</SubstanceName>
<StrengthNumber>
2.5
</StrengthNumber>
<StrengthUnit>
mg/.5mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-10-21
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
01-AUG-23
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>